OverviewChartNewsTraderScreen

BVT Knock-Out ABBV/  DE000VM6H9V9  /

EUWAX
2024-09-20  9:42:43 PM Chg.-0.02 Bid10:00:40 PM Ask10:00:40 PM Underlying Strike price Expiration date Option type
3.90EUR -0.51% -
Bid Size: -		 -
Ask Size: -		 AbbVie Inc 150.00 USD 2078-12-31 Call
GlobeNewswire 08-29 Great Place To Work Announces the 2024 Best Workplaces in Asia Representing 6.9 Million Employee Exp...
GlobeNewswire 08-28 Royalty Pharma to Present at Morgan Stanley’s 22nd Annual Global Healthcare Conference
GlobeNewswire 08-28 Nxera Pharma Notes Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568
GlobeNewswire 08-23 NurExone Biologic Invited to Present Groundbreaking ExoPTEN Therapy at Prestigious September Confere...
GlobeNewswire 08-19 TEPKINLY® (epcoritamab) Receives Second European Commission Approval for the Treatment of Adults wit...
GlobeNewswire 08-15 Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of ...
GlobeNewswire 08-15 Soleno Therapeutics Announces Updates to its Board of Directors
GlobeNewswire 08-14 ArriVent BioPharma Reports Second Quarter 2024 Financial Results
GlobeNewswire 08-09 Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter and First Half 2...
GlobeNewswire 08-08 CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 08-08 Aligos Therapeutics Strengthens Board with Two New Independent Directors
GlobeNewswire 08-08 Genmab Announces Financial Results for the First Half of 2024
GlobeNewswire 08-08 Genmab Updates 2024 Financial Guidance
GlobeNewswire 08-08 Royalty Pharma Reports Second Quarter 2024 Results
GlobeNewswire 08-07 Alector Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 08-06 Caribou Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 08-01 Outpace Bio Announces $144M Oversubscribed Series B Financing to Advance AI-powered Cell Therapies i...
GlobeNewswire 08-01 CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024
GlobeNewswire 08-01 NodThera Announces Appointment of Greg Chow as Chief Financial and Business Officer
GlobeNewswire 08-01 Otsuka Pharmaceutical to Acquire Jnana Therapeutics Inc.
GlobeNewswire 07-31 Fate Therapeutics Appoints Neely Mozaffarian, MD, PhD, FACR, to its Board of Directors
GlobeNewswire 07-31 Umoja Biopharma Announces FDA Clearance of IND Application for UB-VV111, a CD19 Directed in situ CAR...
GlobeNewswire 07-30 Montara Therapeutics Closes $8 Million Seed Round Led by SV Health Investors’ Dementia Discovery Fun...
GlobeNewswire 07-28 Alector Presents Baseline Characteristics for INVOKE-2 Phase 2 Clinical Trial of AL002 at the Alzhei...
GlobeNewswire 07-25 Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Tre...